Differential regulation of B-cell proliferation by IL21 in different subsets of chronic lymphocytic leukemia
Ghasem Ghalamfarsa(Yasuj University of Medical Sciences), Fazel Shokri(Academic Center for Education, Culture and Research), Hossein Asgarian‐Omran(University of Tehran), Mehdi Yousefi(Tabriz University of Medical Sciences), Seyed Mohsen Razavi(Firoozgar General Hospital), Farhad Jadidi‐Niaragh(Tabriz University of Medical Sciences), Mohammad Hojjat‐Farsangi(Karolinska University Hospital), Mahmood Jeddi‐Tehrani(Academic Center for Education, Culture and Research), Jalal Khoshnoodi(University of Tehran), Hodjatallah Rabbani(Biotechnology Research Center), Ali Akbar Saboor-Yaraghi(Tehran University of Medical Sciences), Fathollah Tahmasebi(Tehran University of Medical Sciences)
Cited by 22
Related Papers
Nanoparticles and targeted drug delivery in cancer therapy
|Immunology Letters|2017|507
The significant role of interleukin-6 and its signaling pathway in the immunopathogenesis and treatment of breast cancer
|Biomedicine & Pharmacotherapy|2018|312
The paradox of Th17 cell functions in tumor immunity
|Cellular Immunology|2017|222
Small-Molecule Inhibitors of the Receptor Tyrosine Kinases: Promising Tools for Targeted Cancer Therapies
|International Journal of Molecular Sciences|2014|202
A role for Th1-like Th17 cells in the pathogenesis of inflammatory and autoimmune disorders
|Molecular Immunology|2018|194